On March 1, 2021 BiomX Inc. (NYSE American: PHGE), a clinical-stage company developing both natural and engineered phage therapies that target specific pathogenic bacteria, reported that Jonathan Solomon, Chief Executive Officer, will participate in two upcoming virtual investor conferences (Press release, BiomX, MAR 1, 2021, View Source [SID1234575867]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation Details:

Event: Chardan’s 3rd Annual Microbiome Medicines Summit
Date: Monday, March 8, 2021
Time: 10:45 AM EST

Event: H.C. Wainwright Global Life Sciences Conference
Date: Tuesday, March 9, 2021
Time: On-demand beginning at 7:00 AM EST

Live webcasts from the Chardan and H.C. Wainwright presentations will be accessible through the Investors section of the Company’s website at ir.biomx.com/news-events/ir-calendar. Following the events, the webcasts will be archived on the BiomX website.